Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

Immunology Meets Bioengineering: Improving the Effectiveness of Glioblastoma Immunotherapy

Glioblastoma (GBM) therapy has seen little change over the past two decades. Surgical excision followed by radiation and chemotherapy is the current gold standard treatment. Immunotherapy techniques have recently transformed many cancer treatments, and GBM is now at the forefront of immunotherapy re...

Full description

Bibliographic Details
Main Authors: Zahra Fekrirad, Amir Barzegar Behrooz, Shokoofeh Ghaemi, Arezou Khosrojerdi, Atefeh Zarepour, Ali Zarrabi, Ehsan Arefian, Saeid Ghavami
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Cancers
Subjects:
glioblastoma
immunotherapy
oncolytic virotherapy
nanomedicine
nanoparticles
autophagy
Online Access:https://www.mdpi.com/2072-6694/14/15/3698

Internet

https://www.mdpi.com/2072-6694/14/15/3698

Similar Items